Hepatic Neoplasms Clinical Trial
Official title:
A Prospective, Multicenter, Phase III b Clinical Study to Evaluate the Effectiveness of Unenhanced and SH U 555A (Resovist) Enhanced MRI, Compared to Contrast-Enhanced Dual-Phase Spiral CT in Assessing the Correct Final Therapy-Deciding Diagnosis, in Patients With Primary or Secondary Hepatic Malignancies.
Patients with suspicion of primary or secondary hepatic malignancy in whom a radiological examination is needed in order to decide on the most appropriate treatment.
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been
renamed to Bayer Schering Pharma AG, Germany.
Bayer Schering Pharma AG, Germany is the sponsor of the trial.
;
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01906021 -
Study of New Software Used During Ablations
|
N/A | |
| Completed |
NCT02784353 -
Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy
|
N/A | |
| Terminated |
NCT02213692 -
Comparative Study on Liver Resection Between Harmonic Scalpel Versus Crush-clamping Method
|
N/A | |
| Terminated |
NCT00669136 -
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
|
Phase 1 | |
| Terminated |
NCT02866344 -
Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases
|
N/A | |
| Recruiting |
NCT02246634 -
Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
|
N/A |